Market Overview

According to fortune business insights, the global photoacoustic imaging market size was valued at USD 136.4 million in 2025. The market is projected to grow from USD 152.0 million in 2026 to USD 327.4 million by 2034, exhibiting a CAGR of 10.1% during the forecast period. North America dominated the market with a share of 38.46% in 2025.

Photoacoustic imaging is a non-invasive biomedical technique using pulsed laser light to create images of optical absorption contrast within tissues. The analysis shows that the increasing prevalence of cancer and other chronic diseases, coupled with a rising demand for handheld and point-of-care devices, is driving the adoption of these products.

Major Players Profiled in the Market Report:

• FUJIFILM Corporation (Japan)
• Seno Medical (U.S.)
• Advantest Corporation (Japan)
• TomoWave Laboratories, Inc. (U.S.)
• iThera Medical GmbH (Germany)
• Luxonous (Japan)
• Verasonics, Inc. (U.S.)
• Kibero (Germany)
• InnoLas Laser GmbH (Germany)
• LUMIBIRD (France)

Segments

Increasing Product Launches to Drive Hardware Segment Dominance

Based on type, the market is classified into hardware and software. The hardware segment held the largest market share in 2025. This growth is driven by the increasing volume of diagnostic tests for chronic conditions and the rising focus of companies and research institutes on introducing novel instruments and accessories.

High Adoption Rates to Drive Photoacoustic Microscopy (PAM) Segment Expansion

By imaging mode, the market is categorized into Photoacoustic Tomography (PAT), Photoacoustic Microscopy (PAM), and Photoacoustic Endoscopy (PAE). The Photoacoustic Microscopy (PAM) segment dominated the market with a 50.7% share in 2025, owing to its increasing use in vascular imaging, breast lesion characterization, and dermatological applications where it adds diagnostic specificity.

Growing Prevalence of Cancer to Fuel Oncology Segment Growth